Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000162742 | SCV000213214 | likely benign | Hereditary cancer-predisposing syndrome | 2014-08-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000162742 | SCV000253461 | likely benign | Hereditary cancer-predisposing syndrome | 2024-09-30 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002257465 | SCV002538476 | likely benign | Nijmegen breakage syndrome-like disorder | 2021-08-09 | criteria provided, single submitter | curation | |
Prevention |
RCV003952811 | SCV004776261 | likely benign | RAD50-related disorder | 2021-11-10 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |